Adult research participants, aged over 18 years old;
Non small cell lung cancer that requires pathological confirmation;
All stage 3 unresectable non-small cell lung cancer, including stage correction after MDT and stage downgrading after treatment (4 → 3), and stage upregulation due to disease progression (2 → 3);
ECOG physical condition is 0-2;
In addition to study participants who have not received any treatment, study participants who have undergone surgery, chemotherapy, immunotherapy, and targeted therapy are also eligible for enrollment.
You may not be if
Prisoners who are not convenient for close clinical follow-up;
Study participants with contraindications to radiation therapy.
Clareo Health | RAPART in Locally Advanced Non-small Cell Lung Cancer Patients
